GENERIC DRUGS MARKET: BRAND VERSUS GENERIC
Abstract
A generic drug is a product that is comparable to brand/reference listed drug product in dosage form, potency, route of administration, quality and intended use. Generic drugs are equal and within the acceptable bioequivalence range to the brand name drugs. Branded drugs are typically sold at elevated prices as a large substantial human intervention is applied from inception to commercialization. For taking approval of generics, ANDA (Abbreviated New Drug Application) is filed. An approval of generic drug product requires rigorous standards established by the drug authority with respect to identity, strength, quality, purity, and potency. However, some variability can and does occur during manufacturing, for both brand name and generic drugs. When a drug, generic or brand name, is mass-produced, very small variations in purity, size, strength, and other parameters are permitted.
Keywords: ANDA, ICH, NDA
DOI
https://doi.org/10.22270/jddt.v3i2.465Published


How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).